search
for
 About Bioline  All Journals  Testimonials  Membership  News


Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 4, Num. 3, 2005, pp. 99-103

Annals of African Medicine, Vol. 4, No. 3, 2005, pp. 99-103

HORMONAL EVALUATIONS AND ENDOMETRIAL BIOPSY IN INFERTILE WOMEN IN KANO, NORTHERN NIGERIA: A COMPARATIVE STUDY

1M. A. Emokpae, 2P.O. Uadia and 3A. Z. Mohammed

Department of Chemical Pathology, Aminu Kano Teaching Hospital Kano, Nigeria, 2Department of Biochemistry, University of Benin, Benin City, Nigeria and 3Department of Histopathology, Aminu Kano Teaching Hospital Kano, Nigeria
Reprint requests to: M. A. Emokpae, Department of Chemical Pathology, Aminu Kano Teaching Hospital, P.O. B. 3452, Kano, Nigeria. E-mail: biodunemokpae@yahoo.com

Code Number: am05026

Abstract

Background/Objectives: To determine the levels of prolactin, progesterone, follicle stimulating hormone and luteinizing hormone in infertile women in other to assess the contribution of certain endocrinopathies to infertility in the study population, and compared the performance characteristics of histological diagnosis of endometrial biopsies with hormonal evaluations.
Methods:Five hundred and fifty consecutive infertile women over a period of five years (1999-2003) were evaluated. The hormones were determined using ELECSYS 1010 auto analyzer supplied by Roche, Germany, while the endometrial biopsy was performed using dating technique.
Results: Ninety eight (17.8%) out of the five hundred and fifty subjects had measurable hormonal abnormalities. Of these ninety eight subjects, 26.5% had hypergonadotropic – hypogonadism, 19, 3% had hypogonadotropic – hypogonadism, 6.1% had hypergonadotropic hypergonadism and 48% had hyperprolactinaemia. 68.0% of the endometrial biopsies showed various stages of secretory pattern, 14.2% showed endometritis and 0.7% showed stroma-glandular dissociation. The performance characteristics of histological diagnosis of endometrial biopsies was compared with hormonal study.
Conclusion: Endocrine abnormalities was involved in 17.8% of infertile women with 48% of them hyperprolactinaemic. Endometrial biopsy compared favourably well with hormonal evaluations. For effective diagnosis of the cause of infertility in women, endometrial biopsy study will still be complimentary to hormonal evaluations.

Key words: Infertility, hormones, endometrial biopsy

Résumé

Fond/Objectifs : pour déterminer les niveaux de  prolactine, la progestérone, l'hormone de follicule stimulant  et l'hormone lutéinisante  dans les femmes stériles àfin d'évaluer la contribution de certain endocrinopathies à l'infertilité dans la population d'étude et de comparer les caractéristiques de performance de diagnose histologique de biopsies endometriales avec les évaluations hormonales.
Méthode : Cinq cent cinquante femmes stériles consécutives pour une période de cinq ans (1999-2003) ont été évaluées. Les hormones ont été déterminées en utilisant ELECSYS 1010 analyseur automatique  fourni par Roche en Allemagne, pendant que la biopsie endometriale a été exécutée en utilisant la technique de datation.
Résultats : Quatre-vingt-dix-huit (17,8 %) des cinq cent cinquante sujets avait des anomalies hormonales mesurables. De ces quatre-vingt-dix-huit sujets, 26,5 % avaient hypergonadotropic - hypogonadisme, 19,3 % avaient hypogonadotropic - hypogonadisme, 6,1 % avaient hypergonadotropic-hypergonadisme  et  48 %  avaient  hyperprolactinémie.  68,0 %  des biopsies endometriales a montré des étapes différents de modèle sécrétoire, 14,2 % a montré l'endométrite et 0,7 % a montré la dissociation stroma-glandulaire. Les caractéristiques de performance de diagnose histologique de biopsies endometriales étaient par rapport à l'étude hormonale.
Conclusion : les anomalies endocrines ont été impliquées à 17,8 % de femmes stériles.  48 % d'entre eux avait l' hyperprolactinémie. La biopsie endometriale a comparée favorablement bien avec les évaluations hormonales. Pour la diagnose efficace de la cause d'infertilité dans les femmes, l'étude de biopsie endometriale sera toujours complémentaire aux évaluations hormonales.

Mots clés : l'Infertilité, les hormones, la biopsie endometriale

Introduction

Infertility due to endocrine dysfunction was previously thought to be uncommon in African women but with the introduction of immunoassay and other sophisticated technologies in gynecological practice in Africa, this problem has been found to constitute an in important cause of infertility in African women. 1 - 3 The causes of infertility women are many and approximately 40% of couples will have more than one cause for their infertility. 4, 5 Various ovulatory disorders ranging from luteal phase deficiency to anovulation are estimated to account for up to 15% of all infertility problems. 5 Recent advances in endocrinology points to the fact that the hypothalamus – pituitary –ovarian axis is essential for the smooth operation of the mechanism of the endocrine function which leads to ovulation, 6 and priming of the endometrium for implantation of the zygote which has to pass through a normal fallopian tube following fertilization. 7 failure of any of these complex process leads to infertility.

Ovulation may be evaluated by basal body temperature (BBT) charts, unfortunately such charts lack sensitivity8. Endocrine evaluations and endometrial biopsy are more reliable methods of assessing ovulation function. When endometrium is dated, functional abnormalities of the pituitary-ovarian-endometrial axis may be detected as well as other endometrial causes of infertility such as infection/endometritis. 9 However, some authors have reported that the place of endometrial biopsy in the diagnosis of infertility is doubtful because of inconsistency of their findings, error in interpretation, 10 and hazard of pregnancy interruption during the luteal phase as well as the limited therapeutic benefits of the procedure. 11

The objectives of this study therefore was to determine the levels of prolactin, progesterone, follicle stimulating hormone(FSH) luteinizing hormone (LH) in infertile women which will help to assess the contribution of endocrine abnormalities to infertility in the study population and compare the performance characteristics of histological diagnosis of endometrial biopsy with endocrine evaluations. 

Materials and Methods 

The study population are women who were referred to the chemical pathology laboratory from the infertility clinics of Aminu Kano Teaching Hospital, Kano and other hospitals in the catchment areas over a five year period (1999 – 2003). These were patients who complained of inability to conceive for more than one year despite unprotected and regular coitus. Their ages ranged from 25 to 44 years with a mean of 30.1 year. Two hundred and five subjects had primary infertility which three hundred and forty five had secondary infertility.

Five milliliters of blood was collected from the antecubital vein on the 21st day of the menstrual cycle. This was done to assess the luteal phase of the cycle. The blood was allowed to clot for 2hours at room temperature. The sera were obtained after centrifugation at 3000 rpm for 10minutes. The sera were kept frozen at – 20°C until analysed.

FSH, LH, Prolactin and progesterone were analysed using ELECSYS 1010 auto analyzer supplied by Roche, Germany. The analyzer uses the principle of electrochemiluminescence immunoassay technique.

Endometrial biopsies were done on the same day. Each biopsy specimen was fixed in 10% buffered formol-saline, processed routinely and embedded in paratin-wax. The sections were stained in haematoxylin-Eosin. The sections were examined for evidence of secretory activity; the histologic age of the secretory endometrium was compared with the chronological menstrual age. A diagnosis of anovulation was made when the endometrium showed a non secretory pattern despite the fact that the chronological menstrual age was compatible with the luteal phase. While luteal phase deficiency was diagnosed when the histologic age lagged behind the chronological age by 72 or more hours. Any section showing the significant presence of inflammatory cells were classified as endometritis. In stroma-glandular cell dissociation, while the glandular cells are showing evidence of being in the secretory phase, the stroma cells show proliferative pattern.

Results

The hormonal values and endometrial biopsy results of five hundred and fifty infertile women are presented in tables 1, 2 and 3. Of the five hundred and fifty subjects, ninety eight (17.8%) had measurable hormonal abnormalities while four hundred and fifty two (82.2%) had their hormonal values within the normal limits.

Of the ninety eight who had abnormal hormonal levels, twenty six (26.5%) has elevated levels of FSH, LH, diminished level of progesterone and normal prolactin level. This was classified as hypergonadotropic-hypogonadism. Nineteen (19.3%) had diminished levels of FSH, LH and progesterone and normal protactin level (hypogonadotropic-hypogonadism). Six subjects (6.1%) had elevated levels of FSH, LH, progesterone and normal prolactin level (hypergonadotropic-hypergonadism). While forty seven subjects (48%) had elevated level of prolactin, low limit of normal FSH and normal levels of LH and progesterone (Table 1).

Table 2 shows the histological diagnosis of endometrial biopsy in the study group. Of the total number, three hundred and seventy four (68.0%) showed various stages of secretory patterns ranging from early secretory phase (25.5%), mid-secretory phase (28.0%) and late secretory phase (14.5%). Twenty (3.6%) biopsies showed proliferative phase, seventy eight (14.2%) showed endometrial hyperplasia, forty six biopsies (8.4%) showed inflammatory endometrium (endometritis) and four (0.7%) showed stroma-glandular dissociation. Twenty eight (5.1%) showed decidual reaction.

Table 1: Serum hormonal levels in infertile women

Group

Mean age
(Years)

Mean ± SEM

 

 

 

 

 

Prolactin
Reference range:
72-511 miu/ml

FSH
Reference range:
3.6-7.7 miu/ml

LH
Reference range:
4.3-11.4 miu/ml

Progesterone Reference range:
1.7-27ng/ml

Hypergonadotropic– hypogonadism (n=26)

28.6

276.4+ 5.32

27.8+ 3.48

20.09+ 1.49

0.614+ 0.02

Hypogonadotropic – hypogonadism (n=19)

30.8

470.6+ 5.29

2.26+ 0.12

2.40+ 0.17

0.602+ 0.04

Hypergonadotropic - hypergonadism
(n=6)

30.2

316.3+ 48.1

25.8+ 12.4

20.1+ 8.41

50.29+ 3.50

Hyperprolactinaemia
(n=47)

33.8

855.4+ 71.8

3.52+ 0.25

6.00+ 0.57

13.43+ 2.44

Normal hormonal levels
(n = 452)

36.7

270.6+ 5.39

5.36+ 0.05

7.16+ 0.09

10.81+ 0.31

Table 2: Endometrial biopsies in infertile women

No. (n=550)

Mean age (years)

Histological diagnosis

%

Indication

20

29.0

Proliferative phase

3.6

Preovulatory (anovulation)

140

29.2

Early secretory phase

25.5

Post ovulation

154

30.1

Mid secretory phase

28.0

Post ovulation

80

31.2

Late secretory phase

14.5

Post ovulation

28

30.8

Decidual reaction

5.1

Evidence of pregnancy

46

31.2

Inflammatory endometrium (endometritis)

8.4

Evidence of infection

28

30.9

Endometrial hyperplasia

5.1

Anovulation

4

28.2

Stroma glandular dissociation

0.7

Anovulation

Table 3: Comparison of hormonal levels with histological diagnosis of endometrial biopsies in infertile women

Hormonal groups

Prolactin
miu/ml

FSH
miu/ml

LH
miu/ml

Progesterone ng/ml

Histological diagnosis of endometrial biopsy

Hypergonadotropic-hypogonadism
n=26

276.4+5.32

 

27.8+3.48

20.09+1.49

0.614+0.02

Endometrial hyperplasia, n=6 proliferative endometrium ,n=20

Hypogonadotropic-hypogonadism
n=19

470.6+0.29

2.26+0.12

2.40+0.17

0.602+0.04

Endometrial hyperplasia, n=19

Hypergonadotropic-hypergonadism
n=6

316.3+48.1

25.8+12.4

20.1+8.41

50.29+3.59

Secretory endometrium, n=4
stroma glandular dissociation, n=2

Hyperprolactinaemia
n=47

855.4+71.8

3.52+0.25

6.00+ 0.57

13.43+ 2.44

Secretory endometrium, n=6
Anovulation, n=37
inflammatory endometrium, n=2
stroma-glandular dissociation, n=2

Normal hormonal levels
n=452

270.6+5.39

5.36+0.05

7.16+0.09

10.81+0.31

Decidual reaction, n=28
secretory endometrium, n=364
inflammatory endometrium, n=44
endometrial hyperplasia, n=11

Table 3 shows the endometrial diagnosis of biopsies in the various groups to which the subjects are stratified according to their hormonal evaluations. Of the twenty six subjects who had hypergonadotropic-hypogonadism, endometrial hyperplasia was observed in six biopsies, while proliferative endometrium was observed in twenty biopsies. Endometrial hyperplasia was observed in all nineteen biopsies in nineteen subjects with hypogonadotropic-hypogonadism. Of the six subjects with hypergonadotropic hypergonadism, four biopsies showed secretory endometrium and two showed stroma-glandular dissociation. While out of the forty seven with hyperprolactinaemia, only six showed secretory endometrium, thirty seven biopsies showed hyperplastic endometrium while two each showed inflammatory endometrium and stroma-glandular dissociation. Those whose hormonal levels were within normal limits, twenty eight biopsies showed decidual reaction, three hundred and sixty showed secretory endometrium, forty four showed endometritis and endometrial hyperplasia was observed in eleven biopsies.

Discussion

Even though there information exists about hormonal levels in infertile women in other regions of Nigeria11 - 13 such information is scanty in Kano and none has compared histological endometrial biopsy diagnosis with hormonal levels in infertile women. The causes of infertility in the female are numerous. Rhythmic changes occur in the hormones secretion at all levels of the reproductive system. Anovulation is becoming frequently diagnosed in patients with infertility and menstrual cycle irregularity. 14 The physiology of ovulation and management of ovulation dysfunction are important in the treatment of female infertility. After adequate diagnostic evaluation of the cause of anovulation, several treatment modalities are available that restore ovulation function and menstrual cycle. Ovarian inactivity is indicated when there is a low FSH, LH and progesterone level which means that there is failure at the hypothalamus or pituitary (hypogonadotropic-hypogonadism) whereas high FSH, LH and low progesterone indicates that the primary failure lies in the ovaries (hypergonadotropic-hypogonadism). 14

Our results indicate that 26.5% of those with hormonal abnormalities had hypergonadotropic-hypogonadism, an indication that failure to conceive may lie in the ovaries. This was corroborated by histological endometrial biopsy, which showed endometrial hyperplasia and proliferative endometrium.Hypogonadotropic-hypogonadism which was found in 19.3% of the patients indicates that there may be dysfunction of the hypothalamus or the pituitary which are unable to secrete adequate gonadotropins to stimulate the ovary. The endometrial biopsy also supported this finding by the diagnosis of anovulation.

High LH levels with corresponding low FSH values is indicative of polycystic ovarian disease. This was not observed in the population studied, it is advisable to evaluate serum estradiol in polycystic ovarian disease for effective diagnosis. Luteal phase deficiency was found in 12.8% of the study group who had hyperprolactinaemia but normal FSH, LH and low progesterone levels. This may be due to defective progesterone secretion by luteal cells. Other investigators15 had reported that 19% fertile women have occasional cycles that display luteal phase deficiency, only those individuals who have recurrent abnormalities should be treated.

The endometrial biopsy showed that the endometrial secretory pattern lagged behind the chronological menstrual age by over 72hours.

Hyperprolactinaemia was seen in 8.5% of the total number of subjects evaluated. But it accounted for 48% of all subjects with abnormal hormonal levels. Whereas 37% was recorded in Lagos, Nigeria, 13 33% was reported in Maiduguri and 31.6% was reported in Egypt, North Africa. 7 The mechanism by which hyperprolactinaemia leads to menstrual disorders and infertility have been described by several investigators.16, 17 It is important to mention that studies have shown that increased prolactin may render the ovary less responsive to the effects of gonadotropin given exogenously to induce ovulation. Similarly, in animals, high levels of prolactin can directly inhibit ovulation. It has been demonstrated that hyperprolactinaemia severely curtails or even abolishes gonadotropin pulsatility. 18 Although the manner in which prolactin weakens gonadotropin releasing hormone (GnRH) neural output is not clear, it is possible that prolactin excess enhances (via short loop feedback) hypothalamic dopamine turn over and that increased levels of dopamine in turn inhibit GnRH synthesis and/or release.1 

Endometritis is known to cause infertility either by disturbing the cyclic endometrial rhythm or as a result of the accompanying tubal inflammation and secondary anatomical abnormalities which are always present. 19 Endometrial inflammation was present in 8.4% of the study population. This finding is in agreement with that of Ojo et al19 which observed 10.6% in Ife, south Western Nigeria. The causes of inflammation in these women mainly from the subpopulation with normal hormonal levels is not clear, but may be due largely to infections of the genital tract. Mycoplasma, chlamydiaeand bacterial infections are recognized as the major causes of endometritis in infertile women. 4, 19, 20 

This study shows that hormonal abnormalities were present in 17.8% (n – 98)  of infertile women and 48% of those with abnormal hormone levels had increased levels of prolactin. The endometrial biopsies of the patients compared favourably well with hormonal evaluations. For effective diagnosis of the causes of infertility in women, endometrium biopsy study will still be complimentary to hormonal evaluations especially in Africa where infection are known to contribute to infertility.

Acknowledgements

We acknowledge the contributions of all staff of the fertility clinic, chemical pathology and histopathology departments of Aminu Kano Teaching Hospital toward the success of this work.

References

  1. Rebar RW, Kenigsberg D, Hoogen GD, The normal menstrual cycle and the control of ovulation. In: Becker KL (ed). Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, 1990; 778-787
  2. ACOG Technical Bulletin – Managing the anovalation state: medical induction of ovulation. No. 197. Int  J Gynecol Obstet 1994; 47: 306-312
  3. Ujah IA, Lynch CB, McCune G. Ovulation induction in clomiphene resistance polycystic ovarian syndrome by pure FSH (urofollitrophim): a comparison of two regimens. Tropical Journal of Obstetrics and Gynaecology 1991; 9: 35-37
  4. Okonofua F. Infertility and women reproductive health in Africa (Editorial). Afr J Reprod Hlth 1999; 3: 1-3
  5. Ory SJ. The differential diagnosis of female infertility.  In: Principles and practice of endocrinology and metabolism. Lippincott, Philadelphia, 1990: 789-795.
  6. OnG SC, Rahman SS. Induction of ovulation. A review. Singapore J Obstet Gynaecol 1985; 16: 136-147
  7. Iris. A, Kawuwa MB, Habu SA, Adebayo A. Prolactin Levels among infertile women in Maiduguri, Nigeria. Tropical Journal of Obstetrics and Gynaecology 2003: 20: 97-100
  8. Bauman JE. Basal body temperature: unreliable method of ovulation detection. Fertil Steril 1981; 36: 729-756
  9. Fox H, Buckley CH. Pathology of female infertility. In: Anthony PP, ‘Macsworu RNM (eds). Recent advances in histopathology (No. 11). Churchill Livingstone, Edinburgh, 1981; 119-134
  10. Daly DC, Masler A, Rosenberg SM et al. Prolactin production by luteal phase defect endometrium. Am J Obstet Gynecol 1981; 140: 587-590
  11. Wild RA, Sanfillippo JS, Toledo AA. Endometrial biopsy in the infertility investigation. The experiences of two institutions. J Reprod Med 1986; 31: 954-957
  12. Giwa-Osagie OF, Akinla OA, Coker OO, Sanyaolu AO. Prevalence of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea. Trop Geog Med 1983; 35: 163-165
  13. Kuku SF, Akinyanju PA, Ojiefor JO. Serum level of gonadotropins, prolactin and progesterone in infertile female Africans. Int J fertil 1987; 32: 393-398
  14. Olatinwo AWO, Anate M. Induction of ovulation: a review. Niger J Med 1999; 8: 93-98
  15. Isreal SL. Diagnosis and treatment of menstrual disorder and sterility. Harper and Row, New York, 1967: 492 – 496
  16. Ganong WF. The gonads: development and function of the reproductive system. In: Ganong WF (ed). Review of medical physiology. Appleton and Lange, Connecticut,  1997; 396-398
  17. Thorner MO, Vance ML. Hyperprolactinaemia. In: Hiroo I, Kazuo S, Sho Y (eds). Progress in endocrinology (Volume 2). Proceedings of the 8th International Congress of Endocrinology, Elsevier, Kyole 1988
  18. Evans WS, Thorner MO. Mechanisms for hypogonadism in hyperprolactinaemia. Semin Reprod Endocrinol 1984; 2: 9-13
  19. Ojo OS, Onwudiegwu U, Adelusola KA Odesammi WO. Is the endometrial biopsy still relevant in infertility management? Orient Journal of Medicine (Nigeria) 1991; 3: 94 – 97
  20. Llewellyn-Jones D. Infections of the genital tract. In: Fundamentals of obstetrics and gynaecology. 1986;150-15
Copyright 2005 - Annals of African Medicine
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil